Smith & Nephew Plc Director/PDMR Shareholding (7483Q)

TIDMSN.

RNS Number : 7483Q

Smith & Nephew Plc

29 October 2021

SMITH & NEPHEW PLC

29 October 2021

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------------- 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------------- 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------------- 
 Details of the transaction(s): section to be repeated for (i) 
  each type of instrument; (ii) each type of transaction; (iii) 
  each date; and (iv) each place where transactions have been 
  conducted 
 Description of the          Smith & Nephew plc ordinary shares of USD 
  financial instrument,       0.20 each 
  type of instrument 
                            ------------------------------------------------- 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------------- 
 Nature of the transaction   Purchase of ordinary shares through the 
                              Company's Dividend Re-Investment Plan following 
                              the 2021 interim dividend payment on 27 
                              October 2021. 
                            ------------------------------------------------- 
 Date of Transaction         2021 - 10 - 27 
                            ------------------------------------------------- 
 Place of Transaction        London Stock Exchange (XLON) 
                            ------------------------------------------------- 
 
 
                                                                                                Total Ordinary 
                                                                                                 Share Holding 
                                                                             Total Ordinary      as a % of 
                                                                              Share Holding      the Company's 
                                                                              following          ISC following 
 Name                  Director                               Aggregated      the transaction    the transaction 
  (Position)            / PDMR     Price          Volume       information    *                  * 
 Bradley Cannon                                                              77,922.43852 
  (President                                                                  (including 
  Sports Medicine                                             N/A Single      2,414.63870 
  & ENT)               PDMR        GBP13.06288    1.04868      Transaction    in ADS')          0.00880% 
                      ----------  -------------  ----------  -------------  -----------------  ----------------- 
 Phil Cowdy 
  (Chief Business 
  Development 
  & Corporate                                                 N/A Single 
  Affairs Officer)     PDMR        GBP13.06288    83.67835     Transaction   45,493.96621       0.00514% 
                      ----------  -------------  ----------  -------------  -----------------  ----------------- 
 Myra Eskes 
  (President                                                  N/A Single 
  APAC Region)         PDMR        GBP13.06288    23.35315     Transaction   2,928.68131        0.00033% 
                      ----------  -------------  ----------  -------------  -----------------  ----------------- 
 Simon Fraser 
  (President 
  Advanced                                                    N/A Single 
  Wound Management)    PDMR        GBP13.06288    85.03095     Transaction   10,663.59428       0.00120% 
                      ----------  -------------  ----------  -------------  -----------------  ----------------- 
 Skip Kiil 
  (President                                                  N/A Single 
  Orthopaedics)        PDMR        GBP13.06288    74.08913     Transaction   12,202.12693       0.00138% 
                      ----------  -------------  ----------  -------------  -----------------  ----------------- 
 Catheryn 
  O'Rourke                                                                   83,240.14924 
  ( Chief Legal                                                               (including 
  & Compliance                                                N/A Single      6,170.31995 
  Officer)             PDMR        GBP13.06288    435.47055    Transaction    in ADS')          0.00940% 
                      ----------  -------------  ----------  -------------  -----------------  ----------------- 
 Susan Swabey 
  (Company                                                    N/A Single 
  Secretary)           PDMR        GBP13.06288    142.14675    Transaction   49,558.39347       0.00560% 
                      ----------  -------------  ----------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Susan Swabey

Company Secretary

Smith & Nephew plc

Tel: [phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVIILLAFIL

(END) Dow Jones Newswires

October 29, 2021 06:45 ET (10:45 GMT)